Neumora Therapeutics logo
Neumora Therapeutics
NMRA | NASDAQ
Chart Builder DCF Calculator
$0.49
-$0.01 (-2.64%)
At close: Nov 9, 2026, 4:00 PM ET

Neumora Therapeutics Income Statement

Income statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
– – – – – –
5M – 668K – – –
-5M – -668K – – –
-241.16M -263.46M -188.19M -135.87M -237.32M -95.52M
8.34M 19.93M 16.61M 4.56M – –
-236.8M -243.61M -235.66M -130.9M -237.31M -99.27M
-236.93M -243.79M -235.93M -130.9M -237.31M -99.27M
60.09M 62.54M 44.81M 31.12M 24.55M 8.39M
176.07M 200.93M 142.72M 104.75M 212.78M 87.13M
– – – – – –
236.16M 263.46M 187.53M 135.87M 237.32M 95.52M
3.22M – – – – –
– – -668K – – –
241.16M 263.46M 188.19M 135.87M 237.32M 95.52M
130K 178K 268K – – –
163.39M 159.38M 158.83M 151.95M 151.95M 151.95M
163.39M 159.38M 158.83M 151.95M 151.95M 151.95M
-1.45 -1.53 -1.49 -0.86 -1.56 -0.65
-1.45 -1.53 -1.49 -0.86 -1.56 -0.65
-233.37M -242.98M -234.99M -130.31M -236.77M -95.41M
-233.58M -243.61M -235.66M -130.9M -237.31M -95.52M
208K 631K 668K 594K 538K 105K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.